Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter

Cancer Policy

House passes Trump’s spending bill, which now moves to the Senate

The U.S. House of Representatives voted on the so-called “One Big, Beautiful Bill Act,” this week which included drastic, $715 billion cuts to Medicaid that will result in at least 8.6 million people losing health insurance coverage, including cancer patients and survivors.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Cancer Policy

Appeals court removes block on Trump’s anti-union executive order

A three-judge federal appeals court has lifted a lower court order that blocked the federal government from enacting President Trump’s executive order to end collective bargaining by workers at more than a dozen federal agencies.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

In the Archives

Walter Lawrence Jr.: “The National Cancer Act really gave us a lot of enthusiasm about the future.”

As the Trump administration reshapes the cancer research enterprise that was built on the foundation of the National Cancer Act of 1971, the Cancer History Project presents an eyewitness account of the impact of this landmark law.

Bhattacharya cancels NIH all-hands meeting

In an interview with Science, NIH Director Jay Bhattacharya said that his time at the NIH has been a “tough period”—especially for him.

Trump’s healthcare executive order could be a win for pharma

On April 15, President Trump signed a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged by middlemen, and limit Medicare payments for outpatient services provided by hospitals.

April 18, 2025

Vol.51 No.15

Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025

YOU MAY BE INTERESTED IN

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

House passes Trump’s spending bill, which now moves to the Senate

Appeals court removes block on Trump’s anti-union executive order

Walter Lawrence Jr.: “The National Cancer Act really gave us a lot of enthusiasm about the future.”

Bhattacharya cancels NIH all-hands meeting

Trump’s healthcare executive order could be a win for pharma

Renew today!

Subscriber content

Never miss an issue!

Login

Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025

YOU MAY BE INTERESTED IN

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die”

House passes Trump’s spending bill, which now moves to the Senate

Appeals court removes block on Trump’s anti-union executive order

Walter Lawrence Jr.: “The National Cancer Act really gave us a lot of enthusiasm about the future.”

Bhattacharya cancels NIH all-hands meeting

Trump’s healthcare executive order could be a win for pharma

Never miss an issue!

Login

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”